Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Quality-control system
The FS-80 IP system reliably detects improperly sealed cans and twist-off bottle caps. The system improves final-product quality on assembly lines that fill containers under vacuum or pressure, including nitrogen-dosed cans, and it reliably detects low vacuum or pressure at speeds as high as 1300 bottles/min or 2000 cans/min. Industrial Dynamics/filtec, Torrance, CA http://www.filtec.com/ tel. 888.434.5832



Syringe-closing unit
A rotating, 16-head closing unit receives filled syringe bodies and pistons simultaneously. Because air must be vented during the closing process, each syringe is compressed into oval shape briefly, while air is vented at the piston seal. The process does not affect material or syringe properties, and it implements air evacuation under continuous operation. Optima Group Pharma, Green Bay, WI http://www.optima-usa.com/ tel. 920.339.2222



Sanitary clamping
Continental Disc Corporation introduces the SANI-TORQ clamping device to tighten sanitary clamps to a specified torque setting. The new device tightens a standard 1-1/2"–4" (40–100 mm) sanitary clamp with a standard wrench until the proper torque value is reached. An audible click indicates the correct inch-pounds force has been achieved, and a self-limiting feature stops tightening the clamp. SANI-TORQ is left in place until the clamp is removed. Continental Disc, Liberty, MO
tel. 816.792.1500



Blow–fill–seal machine
The Asep-Tech Model 628 blow–fill–seal machine from Weiler features a two-piece stepped base design to facilitate maintenance and product discharge. Model 624 tooling can be used on the Model 628 machine. The Model 628 unit produces sterile, liquid-filled, tamper-evident containers ranging in size from 0.5 mL to 250 mL. Weiler Engineering, Elgin, IL http://www.weilerengineering.com/ tel. 847.697.4900


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here